Northern Trust’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Northern Trust's AMLX Position: Q3 2026 in Review
Northern Trust increased its Amylyx Pharmaceuticals (AMLX) stake by 16% in Q3 2026, buying an estimated $3.5M and bringing the position to 963,871 shares worth $28M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.
Northern Trust first reported a position in AMLX in Q1 2022 and has held it in 19 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Northern Trust held 963,871 shares of Amylyx Pharmaceuticals worth $28M as of Q3 2026.
- Northern Trust bought 132,131 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $3.5M.
- Amylyx Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #1543 holding.
- Northern Trust first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.